[HTML] springer.com

[HTML][HTML] SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study

AM Shields, SE Faustini, HJ Hill, S Al-Taei… - Journal of clinical …, 2022 - Springer
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
被引用次数：52 相关文章

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.

AM Shields, SE Faustini, HJ Hill… - Journal of Clinical …, 2022 - search.ebscohost.com
Background: Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study.

AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner… - 2022 - westmid.openrepository.com
Background: Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study.

AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner… - 2022 - cabidigitallibrary.org
Background: Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study

AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner… - researchsquare.com
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
[PDF] archive.org

[PDF][PDF] SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study

AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner… - scholar.archive.org
SARS-CoV-2 Vaccine Responses in Individuals with Antibody De ciency: Findings From The
COV-AD Study Page 1 Page 1/14 SARS-CoV-2 Vaccine Responses in Individuals with …

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

AM Shields, SE Faustini, HJ Hill… - Journal of Clinical …, 2022 - discovery.ucl.ac.uk
BACKGROUND: Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
[PDF] cam.ac.uk

[PDF][PDF] SARS‑CoV‑2 Vaccine Responses ináIndividuals witháAntibody Deficiency: Findings fromátheáCOV‑AD Study

SWĚFMĚNVĚHWĚGHĚ … - Journal of Clinical …, 2022 - repository.cam.ac.uk
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

AM Shields, SE Faustini, HJ Hill… - Journal of Clinical …, 2022 - eprints.whiterose.ac.uk
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

AM Shields, SE Faustini, HJ Hill, S Al-Taei… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …